Published online 15 November 2004
Nucleic Acids Research, Vol. 32 No. 20 © Oxford University Press 2004; all rights reserved
RNA interference using boranophosphate siRNAs: structureactivity relationships
1 Department of Molecular Genetics and Microbiology, Box 3020, Duke University Medical Center, Durham, NC 27710, USA, 2 Department of Chemistry, Box 90354, Duke University, Durham, NC 27708, USA, 3 School of Medicine, Duke University Medical Center, Durham, NC 27710, USA and 4 Division of Pediatric Infectious Disease, Department of Pediatrics, Box 3461, Duke University Medical Center, Durham, NC 27710, USA
* To whom correspondence should be addressed. Tel: +919 684 9590; Fax: +919 684 8735; Email: alexa005{at}mc.duke.edu
The authors wish it to be known that, in their opinion, the first two authors should be regarded as joint First Authors
Received February 24, 2004; Revised May 20, 2004; Accepted October 25, 2004
In RNA interference (RNAi), short double-stranded RNA (known as siRNA) inhibits expression from homologous genes. Clinical or pre-clinical use of siRNAs is likely to require stabilizing modifications because of the prevalence of intracellular and extracellular nucleases. In order to examine the effect of modification on siRNA efficacy and stability, we developed a new method for synthesizing stereoregular boranophosphate siRNAs. This work demonstrates that boranophosphate siRNAs are consistently more effective than siRNAs with the widely used phosphorothioate modification. Furthermore, boranophosphate siRNAs are frequently more active than native siRNA if the center of the antisense strand is not modified. Boranophosphate modification also increases siRNA potency. The finding that boranophosphate siRNAs are at least ten times more nuclease resistant than unmodified siRNAs may explain some of the positive effects of boranophosphate modification. The biochemical properties of boranophosphate siRNAs make them promising candidates for an RNAi-based therapeutic.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
K. Sipa, E. Sochacka, J. Kazmierczak-Baranska, M. Maszewska, M. Janicka, G. Nowak, and B. Nawrot Effect of base modifications on structure, thermodynamic stability, and gene silencing activity of short interfering RNA RNA, August 1, 2007; 13(8): 1301 - 1316. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. De Paula, M. V. L.B. Bentley, and R. I. Mahato Hydrophobization and bioconjugation for enhanced siRNA delivery and targeting RNA, April 1, 2007; 13(4): 431 - 456. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Dowler, D. Bergeron, A.-L. Tedeschi, L. Paquet, N. Ferrari, and M. J. Damha Improvements in siRNA properties mediated by 2'-deoxy-2'-fluoro-{beta}-D-arabinonucleic acid (FANA) Nucleic Acids Res., March 22, 2006; 34(6): 1669 - 1675. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. H. S. Hall, J. Wan, A. Spesock, Z. Sergueeva, B. R. Shaw, and K. A. Alexander High potency silencing by single-stranded boranophosphate siRNA. Nucleic Acids Res., January 1, 2006; 34(9): 2773 - 2781. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Juliano, V. R. Dixit, H. Kang, T. Y. Kim, Y. Miyamoto, and D. Xu Epigenetic manipulation of gene expression: a toolkit for cell biologists J. Cell Biol., June 20, 2005; 169(6): 847 - 857. [Abstract] [Full Text] [PDF] |
||||


